#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Monogenic diabetes Non-renal cell carcinoma of kidney Alpha-1 antitrypsin deficiency Chronic hepatitis B Myelofibrosis Alveolar proteinosis Meningitis meningococcal Myxoid liposarcoma Systemic mastocytosis Malignant neoplasm of choroid HER2 gene amplification Extra-osseous Ewing's sarcoma metastatic Adrenoleukodystrophy Leber's congenital amaurosis Pulmonary alveolar haemorrhage More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis – Life with Disease Proteus syndrome – Diagnostics Rett syndrome – Diagnostics Pleomorphic leiomyosarcoma – Basic Information Alternating hemiplegia of childhood Immunodeficiency congenital – Diagnostics Synovial sarcoma metastatic Hereditary angioedema – Basic Information Pituitary-dependent Cushing’s syndrome – Life with Disease Netherton’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Febuxostat Hemihydrate Avalglucosidase Alfa NADOFARAGENE FIRADENOVEC Pimecrolimus Trazodone Wt1 Lamp Mrna Dc Interleukin-2 Mrna-3210 IMEROPRUBART Rasagiline Vidutolimod Macitentan Fentanyl Glycopyrronium Bromide Arachis Hypogaea Flour Tirbanibulin Belzutifan Betaxolol Flortaucipir (18F) Emraclidine More therapies…

    Learn about Your Condition

    Colorectal cancer stage II Vulval cancer Breast neoplasm Trigeminal neuralgia Klinefelter's syndrome Inborn error of metabolism Fibromyalgia Pancreatitis relapsing Hepatic adenoma Spinal pain Adrenogenital syndrome Cholangiocarcinoma Bacterial infection Cough Dedifferentiated liposarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Fakultni Nemocnice Plzen

Fakultni Nemocnice Plzen

Alej Svobody 923/80, Plzen, 323 00, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Betamethasone Sodium Phosphate Ph. Eur
    • Caffeine
    Czechia France Germany Greece Italy Poland +1

  • Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Apalutamide
    Austria Belgium Czechia Denmark Finland Germany +7

  • Study Comparing Sonrotoclax and Zanubrutinib with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Venetoclax
    • Zanubrutinib
    Austria Czechia France Germany Italy The Netherlands +3

  • Study of XXB750 and Drug Combination for Patients with Heart Failure

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Cilazapril
    • Enalapril Maleate
    • Eprosartan Mesilate
    Bulgaria Czechia Denmark France Germany Hungary +5

  • Study Comparing Acalabrutinib and Venetoclax with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    3 1 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Venetoclax
    • Obinutuzumab
    Czechia France Hungary Poland Spain

  • Study on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Zibotentan
    • Dapagliflozin
    Belgium Czechia Germany Italy Poland Slovakia

  • Study of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Fluorouracil
    Czechia Denmark France Germany Ireland Italy +2

  • Study on Niraparib for Maintenance Treatment in Patients with Advanced Ovarian Cancer After Initial Chemotherapy Response

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    Belgium Czechia Denmark Finland France Germany +6

  • Study on the Effectiveness and Safety of OCS-01 Eye Drops with Dexamethasone for Patients with Diabetic Macular Edema

    Not recruiting

    3 1
    Investigated Diseases:
    • Diabetic retinal oedema
    Investigated Drugs:
    • Dexamethasone
    Bulgaria Czechia France Germany Italy Spain

  • Study on the Effectiveness and Safety of Belzupacap Sarotalocan for Patients with Small Choroidal Melanoma or Indeterminate Lesions

    Not recruiting

    3 1
    Investigated Drugs:
    • Belzupacap Sarotalocan
    Austria Belgium Czechia Denmark France Germany +6
Previous Page
1 … 5 6 7 8 9 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!